RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+14.22%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$949M
AUM Growth
+$949M
(+4.1%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
31.29%
Holding
98
New
10
Increased
21
Reduced
41
Closed
15
Top Buys
| 1 |
Eli Lilly
LLY
|
$38M |
| 2 |
Zimmer Biomet
ZBH
|
$20.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.4M |
| 4 |
Intuitive Surgical
ISRG
|
$11.6M |
| 5 |
Procept Biorobotics
PRCT
|
$9.86M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$21.1M |
| 2 |
Tenet Healthcare
THC
|
$9.77M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$9.44M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$8.61M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$8.33M |
Sector Composition
| 1 | Healthcare | 99.42% |
| 2 | Industrials | 0.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exact Sciences
EXAS
$9.33B
| $16.4M | 1.73% |
175,000
+85,000
| +94% | +$7.98M |
|
|
SWAV
27
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $16M | 1.68% |
56,000
-11,000
| -16% | -$3.14M |
|
|
28
Intuitive Surgical
ISRG
$158B
| $15M | 1.59% |
44,000
+34,000
| +340% | +$11.6M |
|
29
Danaher
DHR
$143B
| $14.4M | 1.52% |
60,000
+15,000
| +33% | +$3.6M |
|
|
IMGN
30
DELISTED
Immunogen Inc
IMGN
| $14.2M | 1.49% |
750,000
-500,000
| -40% | -$9.44M |
|
31
Privia Health
PRVA
$2.84B
| $12M | 1.27% |
460,000
+64,333
| +16% | +$1.68M |
|
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $11.6M | 1.22% |
230,000
-41,062
| -15% | -$2.07M |
|
33
Alkermes
ALKS
$4.95B
| $11M | 1.15% |
350,000
+215,000
| +159% | +$6.73M |
|
34
IQVIA
IQV
$31.4B
| $10.6M | 1.11% |
47,000
+26,000
| +124% | +$5.84M |
|
|
35
Procept Biorobotics
PRCT
$2.11B
| $9.86M | 1.04% |
+279,000
| New | +$9.86M |
|
36
Natera
NTRA
$23B
| $9.73M | 1.03% |
200,000
-17,000
| -8% | -$827K |
|
37
Dynavax Technologies
DVAX
$1.19B
| $9.04M | 0.95% |
700,000
-25,000
| -3% | -$323K |
|
38
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.55M | 0.9% |
45,000
-31,000
| -41% | -$5.89M |
|
39
Lantheus
LNTH
$3.75B
| $8.39M | 0.88% |
+100,000
| New | +$8.39M |
|
40
10x Genomics
TXG
$1.66B
| $7.59M | 0.8% |
136,000
-14,000
| -9% | -$782K |
|
|
KRTX
41
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $7.59M | 0.8% |
35,000
-2,000
| -5% | -$434K |
|
42
BioNTech
BNTX
$24.1B
| $7.56M | 0.8% |
70,000
-22,000
| -24% | -$2.37M |
|
43
Harmony Biosciences
HRMY
$2.16B
| $7.39M | 0.78% |
210,000
+40,000
| +24% | +$1.41M |
|
44
Outset Medical
OM
$245M
| $7.23M | 0.76% |
330,635
-229,365
| -41% | -$5.02M |
|
45
Veeva Systems
VEEV
$44.4B
| $6.92M | 0.73% |
35,000
-2,000
| -5% | -$395K |
|
46
Glaukos
GKOS
$5.42B
| $6.76M | 0.71% |
95,000
+3,000
| +3% | +$214K |
|
47
Molina Healthcare
MOH
$9.6B
| $6.54M | 0.69% |
+21,700
| New | +$6.54M |
|
48
Cytokinetics
CYTK
$5.98B
| $6.52M | 0.69% |
200,000
-5,000
| -2% | -$163K |
|
|
ITCI
49
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.02M | 0.63% |
95,000
-10,000
| -10% | -$633K |
|
50
Iovance Biotherapeutics
IOVA
$800M
| $5.98M | 0.63% |
850,000
+163,830
| +24% | +$1.15M |
|